3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
71
Recurrence
7
Smoldering Multiple Myeloma
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Neoplasms
4
Immunoglobulin Light-chain Amyloidosis
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Plasmablastic Lymphoma
2
Neoplasms, Plasma Cell
2
Lymphoma
2
Leukemia, Myeloid, Acute
2
Plasmacytoma
1
Paraproteinemias
1
Non-small Cell Lung Cancer With STK11/LKB1 Mutation
1
Myelodysplastic Syndromes
1
Lymphoma, Large B-Cell, Diffuse
1
Leukemia, Plasma Cell
1
Glioblastoma
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Rituximab
30
acalabrutinib
15
ibrutinib
13
Cyclophosphamide
13
Lenalidomide
12
CT-P10
12
zanubrutinib
9
venetoclax
9
Magnetic Resonance Spectroscopy
9
Specimen Handling
8
obinutuzumab
7
Cytarabine
7
Biopsy
7
Bendamustine Hydrochloride
7
pirtobrutinib
6
glofitamab
6
fludarabine
6
fludarabine phosphate
5
Peripheral Blood Stem Cell Transplantation
5
Cyclosporine
5
brexucabtagene autoleucel
4
Whole-Body Irradiation
4
Vincristine
4
Mycophenolic Acid
4
Etoposide
4
Doxorubicin
4
Stem Cell Transplantation
3
Sirolimus
3
Methotrexate
3
Cyclosporins
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Mantle-Cell
×
daratumumab
×
90 days
×
Clear all
No trials found.